NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy

NCT04781309 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
12
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborators